Skip to main content

Author: Johnny Green

Mexico Extends Cannabis Legalization Deadline, Again

In late 2018 Mexico made international headlines and turned heads in the global cannabis community when Mexico’s Supreme Court ruled that cannabis prohibition was unconstitutional.

When the Supreme Court rendered the decision, it mandated that lawmakers in Mexico pass a cannabis legalization measure to codify the decision and work to implement the new law.

Originally, the Court issued a one-year deadline. Unfortunately, as the one-year deadline approached, it was obvious that lawmakers in Mexico would not be able to comply with the mandate.

Lawmakers in Mexico were granted a new deadline, April 2020, and that extension was also not met due to COVID. Yet another deadline was granted, and yet another time the deadline could not be met, as reported by Reuters:

Mexico’s President Andres Manuel Lopez Obrador on Tuesday blamed small draft errors for a delay in approving a new law that would legalize cannabis and effectively create one of the world’s largest weed markets.

The bill was due to be approved by Dec. 15, but it has been delayed to next year, with the Supreme Court setting a new deadline of April 30 for the law to be passed, according to local media.

Lopez Obrador said legislators requested a delay as time had run out before the current session in Congress ended this month, meaning there was not enough time to review the bill.

The legalization saga in Mexico continues. Will the latest deadline be met, or will another extension be requested? Only time will tell.

Lawmakers in Mexico have expressed optimism on several occasions just for that optimism to deflate. Eventually, Mexico will push the effort over the top, but it is anyone’s guess when that will be. Hopefully, it is sooner rather than later.

Ready, Set, Thai Canna Tour?

Thailand plans a tour to educate locals about medical cannabis. Fully-fledged production is the goal, but will this lead to other things – like organized canna tourism for foreigners?

Tourism and Sports Minister Phiphat Ratchakitprakam has announced that the federal agency is backing a formal medical marijuana tour. The idea is to increase awareness of the medical efficacy of cannabis among locals who are interested in venturing into cultivation.

According to the Bankok Post, 8 provinces have plantations that will serve as part of the tour, and anyone can purchase a tour package, which includes visiting the farms, and education about how to grow the plant commercially.

The Thai government is also moving fairly quickly to implement not only reforms but the infrastructure necessary to nurture a cannabis industry. In August of this year, the Thai cabinet approved an amendment to the country’s Narcotic Act to allow private medical practitioners, traditional healers, and farmers to grow cannabis for medical treatment. Just two years ago on Christmas Day, the government approved the medical use of cannabis, becoming the first country in Southeast Asia to legalize cannabis for medical purposes.

The Implications Elsewhere

There are still few governments that seem to be as open to creating a national economy for locals as the way the Thai government appears to be going about legalization. In most countries, starting with Europe but also including Australia, New Zealand, and South Africa, the entire process of cannabis cultivation has been limited to existing farmers or cultivators who could raise significant amounts of cash to begin construction of specialized grow facilities and a supply chain that would pass medical muster.

The Thai government, however, appears to be taking a vastly different tact. Namely, making sure that national farmers are given the first opportunity to enter the market and keep control of a commodity that so far has mostly been dominated by those with deep pockets and from elsewhere.

This attempt to keep the cannabis market in local hands may well still traverse the path seen elsewhere – namely selling itself to foreign investors to raise capital for a fully licensed supply chain. However, it also may not. There is considerable backlash growing against the Canadian public industry, in particular. And more and more countries are beginning to understand that keeping cannabis production local is a vital element of national security, just like the ability to grow other food and plants for medicine.

Indeed, the Thai experiment may yet produce its own exotic strain of reform in the coming years that may well leapfrog its way into other national discussions.

Make sure to book your tickets to the International Cannabis Business Conference when it returns to Europe in 2021.

New Book On German Cannabis Cultivation Tender Pulls No Punches

Marguerite Arnold goes behind the scenes of the exploding German cannabis market at a critical time – the first cultivation bid.

In this fascinating, hard to put down, and perfect digital Christmas stocking stuffer, Marguerite Arnold, among other things, a veteran “foreign” cannabis correspondent, tells a story that is absolutely an insider’s account of the holy mess made by authorities and companies alike as everyone scrambled to be first in this foreign green gold rush and as modern reform came to Europe.

This is, at heart, the story of the first federal cultivation bid for the cultivation and distribution of medical cannabis in Germany – but the story stretches far beyond just that.

Green II: Spreading Like Kudzu is a lot of things – but here are a few ways to describe it – starting with being the first business book about the German and European cannabis industry. It is hard to categorize the Ebook generally beyond that – except for the fact that it is one of the few so far to cover it in ways that are both professional snapshot and intriguing for other reasons (even for people with no idea what reverse mergers or cannabinoids are). As such it is part a must-read for anyone considering entering the European if not global cannabis trade (and Arnold’s explanations of the securities exploits of the Canadian public companies is a priceless, well-documented epic, worth just the price of the book alone).  So is her easy-to-read description of some of the bigger issues about regulation and certification.

It is well-written and sourced, authoritative and often funny. As such it will also be a great introduction to the entire cannabis discussion for any relatives or colleagues with questions. Not to mention aspiring canna MBAs with international inclinations. Indeed, one of the more intriguing parts of the book is also the preface where Arnold briefly describes her own cannabis themed journeys – including winning a German Supreme Court case that is already considered one of the most important “Right To Return” reforms to domestic immigration law since WWII.

But Green is also part travelogue and time travel trip too. Arnold’s visit to a Polish cannabis safe house is a touching if not fascinating reflection of how the “movement” in Europe is still reminiscent of the scene in California, New York and Washington DC in the 80’s and 90’s – no matter how removed in geography and time. Her discussion of the politics and socioeconomic questions are also interesting, particularly coming at a time of such massive change for Germany and Europe as well as the Brexiting UK far beyond just cannabis. She also profiles leading experts, such as Dr. Franjo Grotenhermen, Raphael Mechoulam, and, from the private sector, international cannapreneurs she obviously encounters on a regular basis.

Of course it is hard to be entirely objective. She also gives the International Cannabis Business Conference kudos as the most important business conference on the planet!

Here is a brief excerpt from Chapter 4 about the conference itself:

The Cannes of Cannabis

On the first day of April, Alex Rogers strode onto a stage at a central Berlin conference hotel just two blocks from the Spree River that meanders through the middle of the city. He was here to open the third annual International Cannabis Business Conference. In front of him were close to a thousand people – all working in, in some capacity, the international legal cannabis industry from all over the world. Literally. 

The International Cannabis Business Conference is a professional conference so there are not many “wanna-bes” who show up. People who come are invested in a serious way, no matter how big or small the amount, in an industry they want a ground floor entry to as the entire conversation continues to get disruptive.

Even those who deliberately stayed home this year sent a message – namely that they could not be there without being put on the spot about burning questions only a closed and still privileged few really were in the know about. Even on that score – namely those with answers about the bid, could not defer the growing rumors, certainly by the second day of the International Cannabis Business Conference, that news about the resolution of the tender was in the air a full week before the second lawsuit against the bid in Düsseldorf had even been heard.

For this reason, including hoping to gain an inside tip on who won and those lining up for sales generated by it by this year, the International Cannabis Business Conference had become a well attended, avidly anticipated conference if not annual event. In the process, the conference has also served to create a unification point for not only a German but budding and nascent cross-European and indeed completely international industry to meet, make friends and do business. Especially as, even in the German market, Berlin was not the de facto “center” of the industry anymore. By this time, major firms and budding distributors were speckled all over the German map (including Cologne, Frankfurt, Munich and even the Ruhrgebeit’s Dortmund).

Attendees ran the gamut of firms too. Sure the big “name” Canadian producers were here. This year, however, as in years past, they also shared the conference with smaller firms now seeing Europe as a clear entry point on their roadmaps. Israelis were here in force, including vape makers Kanabo, unashamedly going head-to-head with industry standard if not fave, the German Storz and Bickel.

Yet everyone here, no matter whether they took a straßenbahn (street car) or hopped several international time zones to attend, had one clear mission: plotting the details if not logistics of their European landing. 

Looking out across this sea of faces on the first day of the International Cannabis Business Conference this year, it was hard for Rogers to contain his pride if not his excitement. This was going to be the best year ever. Attendance was through the roof and the conference sported a record number of sponsored booths and tables.

“Welcome to Berlin and the International Cannabis Business Conference, y’all,” he said, a grin splitting his face from ear to ear. 

“My sister went to Princeton, ” Rogers announced, and then paused, knowing, from experience what the next reaction from the crowd would be.  “And I went to prison.” He couldn’t help laughing himself. There is a happy ending to this story. Rogers is living it large these days.

The attendees’ laughter rippled through the assembled throng like a gurgling brook on a sunny day because it’s a crowd-pleaser every time. Including because, in too many parts of the world, being in the “biz” means taking risks and facing down dangers that seem unimaginable to most people, still.

This opening, understandably, is one of Rogers’ favorite lines, but it also sums up a section of his career path well. It may be alliterative and kind of humorous too, but it also has the poignancy of a man who has paid his dues. If not literally done his time. And that after meeting what only the most hardened entrepreneur in any industry would not call a major setback, making the choice to survive and as a result, thrive in the new era of the cannabis industry – internationally.

Rogers is a tall, rangy, GI-Joe handsome and intense man with greying sideburns. Not to mention a supreme distaste for anyone who still resists the cannabis flood.  He is, if one can give a political label to it, “pro cannabis,” and tends to fall within the more libertarian part of the industry. 

Rogers also belongs to the part of the biz that no matter his current incarnations, who worked for legalization in the “old days.” As a result, he is also, like many of his peers, of the mind-set that the present can be characterized as such: the fucking drug cures cancer, is awesome for the right people recreationally too, should be regulated and does not cause insanity much less male titties. You lost the drug war, assholes. Now let me just get on with my business, damnit.

Apart from being no bullshit, however, Rogers is also bottom line focused and has managed, without the direct support of any established “cannabis player” or “power” except a highly dedicated team, to create an intriguing brand all of his own. The vibe at the International Cannabis Business Conference in Berlin as a result, manages to encapsulate the funky edginess of the scene, both presently and even a bit of its bygone days, while being clearly a deals conference par excellence. 

Even from its first year, the conference saw intense commercial activity that looked most like, truth be told, bidding wars at top film festivals rather than national agricultural promotion fairs (which is what they also function as). The former seems a bit hipper (the fashion sense certainly is). Pricing and commodity swaps and contracts aside, the characters and pure international eccentricity is certainly more like the film industry than say your average county or even national produce market. 

Even at an international level. 

And especially given the subject matter at hand. 

Cannabis users or those connected to the industry in any way can increasingly wear their “flower power” paraphernalia, pass out business cards, have LinkedIn profiles, in Europe even bank accounts, and more with pride these days. 

And are everywhere.

That comes in many flavors.

For those of a certain age who grew up literally terrorized by the Drug War, the first day of April 2019 in Berlin at the International Cannabis Business Conference certainly felt again, like a kind of vindication and a marker of a revolution that this time, will not be stopped. 

This time, globally.

Green II: Spreading Like Kudzu is now available

The European Commission Revises Its Stance On CBD As A Narcotic

While the WHO essentially punted on cannabis reform last week, there was a bit of bright news on the horizon in Europe – namely that the European Commission revised its stance on the idea that CBD should be treated as a narcotic.

This is a huge development, although not unsurprising given the recent ruling in Strasbourg on the right to import “legally” produced CBD between European countries based on the trial of a French company engaged in the same.

However, this development is still tempered with the fact that the WHO has kept the plant itself (the genus Cannabis Sativa L) as a Schedule I plant. That includes hemp.

Ultimately, however, beyond this distinction, the jury is still out on whether and when European authorities will also decide that the plant and its extracts, by traditional means, are further not “novel,” but rather governed under other regulations (such as EU-BIO). Stay tuned.

Extraction, Processing And Labelling Are All In The Mix

With hemp products of all kinds hitting mainstream grocery stores in Germany, this development will clearly provide at least some forward motion for an industry that has repeatedly hit regulatory jags across the region since 2016. But the fight is far from over.

Novel Food regulation looms as a bane not only of the hemp industry but also of the entire recreational discussion. The reason? The source of the seed plus the method of extraction, as well as its final addition to the end product are all in the mix. 

This is still, in other words, dangerous territory for just about everyone. Understanding the regulations, and how to apply them, are still the most important aspect of all in the mix.

How Does The EC Decision Interact With The WHO Vote?

The first place this will impact is cultivation. Farmers will have to register and certify their crops – starting with all the regulatory steps around organic production (if bound for anything but industrial purposes) and cultivation in the first place.

Beyond that, within Europe, producers will have to be willing to certify their supply chains – although this again may not mandate that the distinction is one that is “novel.” 

Indeed Europe has become a place, much like the United States, where hemp products are almost, but not entirely regulated.

Regardless of the still remaining bumps along the way, however, it is clear that 2021 is going to be a good year for the industry across the EU.

Be sure to attend the next International Cannabis Business Conferences when they return to Europe.

United States House Of Representatives To Vote On Cannabis Legalization This Week

Federal cannabis prohibition was first implemented in the United States in 1937. The initial legislation that was passed by Congress came after a methodical reefer madness propaganda campaign was waged from coast to coast by Harry Anslinger.

Eventually, the legislation was replaced with the Controlled Substances Act in 1970 which placed cannabis in the Schedule I category, where it remains to this day.

Schedule I substances are defined as having ‘no currently accepted medical use and a high potential for abuse.’ Obviously, it doesn’t take a doctor or scientist to know that cannabis is medicine.

A quick search for ‘marijuana’ on PubMed.gov, which is the national database for peer-reviewed studies, returns nearly 35,000 results. Cannabis is absolutely medicine.

Nearly every state in the U.S. has some form of medical cannabis, from CBD-only all the way up to home cultivation and regulated dispensaries. Fifteen states and Washington D.C. have now passed adult-use cannabis legalization measures.

With all of that in mind, federal cannabis prohibition still being in place in the U.S. is unconscionable. In 2021 a number of states are expected to legalize cannabis for adult use through the legislative process, making enforcement of federal cannabis prohibition that much more untenable.

The MORE Act, which would effectively end federal cannabis prohibition in the U.S. and make it a true state rights issue, will receive a vote in the United States House of Representatives this week, where it is expected to pass.

The real hiccup is expected to occur in the United States Senate, which has been less-favorable to cannabis policy compared to the House.

Two seats in the Senate are still to be decided, both in Georgia, so it’s hard to speculate right now what the chances are of the MORE Act passing in the Senate.

But before that speculation even needs to occur, all eyes will be on the U.S. House this week to see if the bill passes in that particular chamber.

United Nations To Vote On Cannabis Rescheduling

This could prove to be a very big week for cannabis at the international level with the United Nations’ Commission on Narcotic Drugs voting on a series of cannabis policy recommendations from the World Health Organization.

The Commission has met on several occasions to discuss the recommendations from the World Health Organization, including a recommendation to reschedule cannabis, however, there has yet to be a vote.

Voting was expected to occur earlier in 2020, but due to various delays, it never happened. That will change tomorrow when the Commission finally votes on the recommendations. Below is what is being considered, as reported by Marijuana Moment:

1. Remove marijuana from Schedule IV of the 1961 Single Convention.

2. Add THC and dronabinol (synthetic THC medication) to Schedule I of the 1961 Convention and, if approved, delete them from Schedule II of the 1971 Convention.

3. If the second recommendation is adopted, add tetrahydrocannabinol to Schedule I of the 1961 Convention and, if approved, delete it from Schedule I of the 1971 Convention.

4. Delete “extracts and tinctures of cannabis” from Schedule I of the 1961 Convention.

5. Add footnote to clarify that CBD products containing no more than 0.2 percent THC are not subject to international control.

6. Add “preparations containing dronabinol” to Schedule III of the 1961 Convention.

Only time will tell what gets approved and what does not. International cannabis policy is extremely outdated, and binding international treaties are often cited by countries as to why lawmakers will not end cannabis prohibition in those countries.

Right now two countries, Uruguay and Canada, have legalized cannabis for adult-use. Dozens of countries have legalized cannabis for medical use. Cannabis is being imported and exported between a growing list of nations.

It is beyond time that international cannabis policy was updated to reflect what is actually happening in the real world.

Cannabis prohibition has failed, and it’s time for a more sensible approach at the global level so that at the national level countries can proceed with getting on the right side of history.

Presidential Decree Permits Cultivation Of Medical Cannabis In Argentina

The cannabis plant possesses tremendous medical value according to tens of thousands of peer-reviewed studies, as well as countless personal experiences among patients.

Cannabis is medicine, despite what cannabis opponents say. The science speaks for itself and outweighs the harmful political views of cannabis opponents.

A number of conditions can be successfully treated with medical cannabis, and fortunately for suffering patients in Argentina they will be able to cultivate their own medical cannabis in some circumstances, as described in a news release from our friends at NORML:

Patients and their caregivers will be able to apply for federal licensure to grow marijuana for medicinal purposes in their homes, according to a Presidential decree issued late last week.

The policy change expands upon a 2017 law that provided a legal exemption under the law for qualifying patients with epilepsy to possess cannabis extracts. However, that law provided to legal source to provide patients with access to plant-derived extracts.

Under the new law, pharmacies will also for the first time be able to provide specific cannabis products to qualifying patients. “We are replacing a black market that already exists with quality control that is key in all medical products, particularly those that are given to children,” said Argentina’s health minister, Ginés González García.

Argentina is one of a number of South American countries, including ChileColombia, and Peru, that has moved in recent years to liberalize medical cannabis access. In July of 2017, pharmacies in Uruguay began selling cannabis products over-the-counter to adults participating in the nation’s marijuana registry.

Cannabis Treatment Admissions Among Youth Decline Sharply In Legalization States

One of the favorite talking points amongst cannabis opponents is ‘what about the children?’ They go to that talking point early and often when a state/country is trying to reform its cannabis laws, warning of dramatic spikes in cannabis use among youth.

For many decades that was an effective talking point in that it scared a lot of people, and it was hard to disprove because cannabis prohibition was in full effect and there wasn’t any data to point to in order to directly debunk the claim.

Fortunately, that has changed in recent years due to the fact that a number of states in the U.S. and two countries have legalized cannabis for adult use.

We all now know that the children will be just fine and that regulation is a better public policy approach compared to prohibition, as highlighted in the results of a recent study. Below is more information about the study via a press release from our friends at NORML:

The number of adolescents admitted to drug treatment programs for marijuana-related issues has fallen precipitously in states that have legalized and regulated its adult-use, according to data published by the US Centers for Disease Control and Prevention.

Commenting on the study, NORML Deputy Director Paul Armentano said, “These findings add to the growing body of scientific literature showing that legalization policies can be implemented in a manner that provides access for adults while simultaneously limiting youth access and misuse.”

The report, entitled Trends in Adolescent Treatment Admissions for Marijuana in the United States, 2008-2017, finds that, nationally, “adolescent treatment admissions for marijuana declined in most of states. The mean annual admissions rate for all states declined over the study period by nearly half, from 60 (admissions per 10,000 adolescents) in 2008 to 31 in 2017.” States experiencing the “steepest level of admissions decline” were among those that had enacted adult-use legalization laws.

While the report’s author suggested various possible reasons for the trend, he did not assess whether declining marijuana admissions rates were correlated with changes in marijuana law enforcement and sentencing. Data published in 2017 in the journal Substance Use & Misuse reported that over half of all young people entered into drug treatment for marijuana are placed there by the criminal justice system.

The CDC report concludes, “[T]his research suggests that a precipitous national decline in adolescent treatment admissions [is occurring], particularly in states legalizing recreational marijuana use.”

Separate studies have similarly reported that the prevalence of problematic marijuana use (so-called cannabis use disorder a/k/a CUD) among young people and adults has declined steadily since 2002.

In addition, a 2019 study published in JAMA Pediatrics concluded: “Consistent with the results of previous researchers, there was no evidence that the legalization of medical marijuana encourages marijuana use among youth. Moreover, the estimates reported … showed that marijuana use among youth may actually decline after legalization for recreational purposes. This latter result is consistent … with the argument that it is more difficult for teenagers to obtain marijuana as drug dealers are replaced by licensed dispensaries that require proof of age.”

Additional information regarding marijuana use patterns among young people is available from the NORML fact sheet.

###

NORML advocates for changes in public policy so that the responsible possession and use of marijuana by adults is no longer subject to criminal penalties. NORML further advocates for a regulated commercial cannabis market so that activities involving the for-profit production and retail sale of cannabis and cannabis products are safe, transparent, consumer-friendly, and are subject to state and/or local licensure. Finally, NORML advocates for additional changes in legal and regulatory policies so that those who use marijuana responsibly no longer face either social stigma or workplace discrimination, and so that those with past criminal records for marijuana-related violations have the opportunity to have their records automatically expunged.

Find out more at norml.org and read our Fact Sheets on the most common misconceptions and myths regarding reform efforts around the country.

Medical Cannabis Is A Big Success According To Thailand’s Public Health Minister

Historically, the Asian continent has been home to some of the harshest cannabis laws on earth, and while that is still true in some countries in Asia, cannabis reform is starting to spread on the continent.

That is most evident in Thailand, where a young medical cannabis program appears to be thriving. In 2018 Thailand became the first country in its region to pass a medical cannabis legalization measure.

Since that time, a growing number of patients have signed up to be able to use medical cannabis legally. According to Thailand’s Health Minister, an overwhelming amount of patients are reporting positive results. Per Bangkok Post:

“At least 70% of patients in over 300 medical cannabis clinics that have opened nationwide say their symptoms have improved since starting treatment, according to Public Health Minister Anutin Charnvirakul. Mr Anutin made the claim at a training session on the use of medical cannabis extracts in Muang district of Buri Ram yesterday.

Mr Anutin made the claim at a training session on the use of medical cannabis extracts in Muang district of Buri Ram on Wednesday.”

It is likely that many countries in Asia that are home to harsh cannabis laws are keeping a close eye on how things are going in Thailand to gauge whether or not they should follow suit.

With that in mind, it’s fantastic to see medical cannabis reform doing so well in Thailand. Hopefully it encourages surrounding nations to pass similar reform measures sooner rather than later.

It likely comes as no surprise to veteran cannabis enthusiasts across the globe that medical cannabis is doing well in Thailand, however, it’s very significant for passive observers to see it happening, especially those in positions of power in Asian countries.